Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome
IBS_FBM
A Pilot Study on the Effect of Electroacupuncture on Functional Brain Mapping in Patients With Irritable Bowel Syndrome
1 other identifier
interventional
42
1 country
1
Brief Summary
Irritable bowel syndrome (IBS) is the most common digestive disorder that affects more than 5% of population in Hong Kong. However, there is no effective treatment of IBS using Western Medicine. Acupuncture, a traditional therapeutic modality, has been used in China for thousands of years for various pain disorders. In addition to analgesia, acupuncture has also been shown to influence physiology of gastrointestinal tract. The investigators set out to evaluate the therapeutic value of acupuncture in IBS. The investigators will study its effects on rectal sensation and brain activity in patients with IBS. All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline assessment includes individual IBS symptoms (pain/discomfort, bloating, constipation, and diarrhea) as perceived by patients will be scored. The syndrome of IBS patients will also be recorded and analyzed based on the Chinese medicine theories. All patients will then undergo baseline rectal barostat for thresholds of rectal sensation. At visit 2, eligible patients will be randomly assigned to either (1) electroacupuncture or (2) sham electroacupuncture treatment groups. Functional Magnetic Resonance Imaging (fMRI) scanning will be performed before, during and after the electroacupuncture or sham electroacupuncture treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2008
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 12, 2009
CompletedFirst Posted
Study publicly available on registry
May 13, 2009
CompletedJuly 2, 2009
June 1, 2009
8 months
May 12, 2009
June 30, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sensory and pain thresholds as determined by rectal barostat
At baseline study visit
Degree of cortical activation as determined by functional MRI
At study visit 2
Study Arms (2)
Electroacupuncture treatment
ACTIVE COMPARATORA specially designed copper needle (0.22 x 4 mm), which can be used safely in MRI suite, will be inserted through a plaster over the respective acupoints, under which a plastic ring will be positioned, connected with electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair) through wires with stimulation frequency of 150 Hz, lasting for 30 minutes.
Sham acupunture treatment
SHAM COMPARATORNeedle will be positioned at 2 cm away from the true respective acupoints, with a blunted, telescopic placebo needle. The same electric stimulation will be the same as real acupuncture treatment.
Interventions
A specially designed copper needle (0.22 x 4 mm), which can be used safely in MRI suite, will be inserted through a plaster over the respective acupoints, under which a plastic ring will be positioned, connected with electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair) through wires with stimulation frequency of 150 Hz, lasting for 30 minutes.
Needle will be positioned at 2 cm away from the true respective acupoints, with a blunted, telescopic placebo needle. The same electric stimulation will be the same as real acupuncture treatment.
Eligibility Criteria
You may qualify if:
- Irritable bowel syndrome of diarrhea type as defined by Rome III criteria
- Age 18-65 years
- Normal colonic evaluation within 12 months (with either colonoscopy or barium study)
You may not qualify if:
- IBS-constipation, mixed or unsubtyped
- Pregnancy
- Medical history of organic colonic bowel disease
- History of sensitivity to acupuncture
- Psychiatric or additive disorder
- Patients who have received acupuncture in the past 6 months
- Concomitant medications including anti-diarrhea agent, anti-depressant, narcotic analgesic and anti-cholinergic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong, Prince of Wales Hospital
Shatin, Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Winnie C.W. Chu, MBChB, FRCR, MD, FHKAM
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 12, 2009
First Posted
May 13, 2009
Study Start
April 1, 2008
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
July 2, 2009
Record last verified: 2009-06